• 1. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 2. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 3. An integrated droplet-digital microfluidic system for on-demand droplet creation, mixing, incubation, and sorting?
  Lab Chip, 2019,19, 524-535
• 4. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
• 5. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034

Introduction to Benzene,1-chloro-4-ethoxy-2-fluoro- (CAS No. 289039-33-4)

Benzene,1-chloro-4-ethoxy-2-fluoro- (CAS No. 289039-33-4) is a fluorinated aromatic compound that has garnered significant attention in the field of pharmaceutical chemistry due to its unique structural and chemical properties. This compound belongs to a class of molecules that exhibit a high degree of versatility in synthetic applications, making it a valuable intermediate in the development of various chemical entities.

The molecular structure of Benzene,1-chloro-4-ethoxy-2-fluoro- consists of a benzene ring substituted with a chlorine atom at the 1-position, an ethoxy group at the 4-position, and a fluorine atom at the 2-position. This specific arrangement of functional groups imparts distinct reactivity and electronic characteristics to the molecule, which can be exploited in various synthetic pathways. The presence of both electron-withdrawing and electron-donating groups on the aromatic ring enhances its participation in electrophilic and nucleophilic aromatic substitution reactions, respectively.

In recent years, there has been growing interest in the development of novel fluorinated compounds due to their enhanced metabolic stability, improved bioavailability, and increased binding affinity to biological targets. Benzene,1-chloro-4-ethoxy-2-fluoro- has emerged as a key building block in the synthesis of fluorinated pharmaceuticals and agrochemicals. Its unique substitution pattern allows for further functionalization at multiple sites, enabling the creation of complex molecular architectures with tailored properties.

One of the most compelling aspects of Benzene,1-chloro-4-ethoxy-2-fluoro- is its role as a precursor in the synthesis of active pharmaceutical ingredients (APIs). Researchers have leveraged its reactivity to develop novel therapeutic agents that target various diseases. For instance, fluorinated aromatic compounds have shown promise in the treatment of cancer, infectious diseases, and neurological disorders. The ability to introduce fluorine atoms into drug molecules often enhances their pharmacokinetic profiles, leading to improved efficacy and reduced side effects.

The synthesis of Benzene,1-chloro-4-ethoxy-2-fluoro- typically involves multi-step organic reactions that require precise control over reaction conditions. Common synthetic routes include chlorination and ethylation of appropriately substituted benzene derivatives followed by fluorination. These reactions are often catalyzed by transition metals or organometallic compounds to ensure high yields and selectivity. The use of advanced computational methods has also facilitated the optimization of synthetic pathways, reducing experimental trial-and-error and improving overall efficiency.

Recent studies have highlighted the importance of Benzene,1-chloro-4-ethoxy-2-fluoro- in medicinal chemistry due to its potential as a scaffold for drug discovery. Researchers have demonstrated its utility in generating libraries of diverse compounds for high-throughput screening (HTS). This approach has led to the identification of novel lead structures with significant therapeutic potential. The compound's ability to undergo further modifications makes it an attractive candidate for structure-based drug design (SBDD) and computationally guided molecular evolution.

The impact of fluorine atoms on the biological activity of molecules is well-documented. Fluorine can influence metabolic stability by preventing oxidative degradation and can enhance binding interactions by increasing lipophilicity or altering electronic distributions. In the context of Benzene,1-chloro-4-ethoxy-2-fluoro-, these effects contribute to its utility as a pharmacophore in drug design. The compound's structural features allow it to interact with biological targets in ways that may not be possible with non-fluorinated analogs.

Advances in analytical techniques have enabled researchers to gain deeper insights into the behavior of Benzene,1-chloro-4-ethoxy-2-fluoro- during synthesis and application. Techniques such as nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry (MS), and X-ray crystallography provide detailed information about molecular structure and dynamics. These tools are essential for verifying the identity and purity of intermediates and final products, ensuring that they meet stringent quality standards for pharmaceutical use.

The future prospects for Benzene,1-chloro-4-ethoxy-2-fluoro- are promising as ongoing research continues to uncover new applications and synthetic strategies. Collaborative efforts between academia and industry are driving innovation in fluorinated chemistry, leading to more efficient synthetic routes and novel drug candidates. As our understanding of molecular interactions improves, compounds like this will play an increasingly important role in addressing unmet medical needs.

• 1369813-97-7(1-Chloro-2-fluoro-4-isopropoxybenzene)
• 909122-16-3(1-Chloro-3-ethoxy-2-fluorobenzene)
• 202925-07-3(3-Chloro-4-fluoroanisole)
• 501-29-1(4-Chloro-3-fluoroanisole)
• 289039-42-5(Benzene,1-chloro-3-ethoxy-5-fluoro-)
• 289039-45-8(Benzene,2-chloro-4-ethoxy-1-fluoro-)
• 85983-24-0(ETHANOL, 2-[4-(3-CHLORO-5-FLUOROPHENOXY)PHENOXY]-)
• 909122-13-0(2-Chloro-1-Ethoxy-3-Fluorobenzene)
• 847547-34-6(BENZENE, 2-CHLORO-1-FLUORO-4-(2-PROPYNYLOXY)-)
• 85983-52-4(BENZENE, 2-CHLORO-1-FLUORO-4-(4-METHOXYPHENOXY)-)